Cargando...
Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice
While the past decade has seen a revolution in understanding of the genetic and molecular etiology of the disease, in clinical practice, initial therapy for acute myeloid leukemia (AML) patients has been a relatively straightforward choice between intensive combination cytotoxic induction therapy as...
Guardado en:
| Publicado en: | Ther Adv Hematol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5900827/ https://ncbi.nlm.nih.gov/pubmed/29713444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620718761778 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|